Please login to the form below

Not currently logged in
Email:
Password:

Amgen promotes Esteban Santos

He succeeds Madhavan Balachandran as executive vice president of operations

Amgen Esteban SantosAmgen has appointed Esteban Santos as executive vice president of operations, with effect from 25 July.

In his new role Santos will take on responsibility for Amgen's operations, which encompasses manufacturing, process development, quality, engineering and its global supply chain, from Madhavan Balachandran who retires at the end of the year.

Santos joined the California-based biotech in 2007 as vice president of global engineering, and subsequently held a number of roles with increasing responsibility at the firm.

He currently serves as senior vice president of manufacturing with responsibility for worldwide product supply - a position he has held since 2013.

Prior to joining Amgen, Santos worked at Cordis, a Johnson & Johnson company, as site general manager for its Puerto Rico operations.

He has also held several management positions at General Electric, including its industrial and transportation businesses in Connecticut, Puerto Rico and Pennsylvania.

Robert Bradway, chairman and chief executive officer at Amgen, said: “Esteban is a talented leader with a proven track record.

“I'm confident that Esteban and our operations team will maintain our track record of industry-leading performance in serving 'every patient, every time' as we expand globally, launch new products and introduce our next-generation of biomanufacturing technologies.”

21st June 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Complete HealthVizion

Complete HealthVizion is a global team of fresh thinkers who aspire to be better every day. We create life-changing medical...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics